2018 Medical Association Poster Symposium Guidelines

Transcription

1 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April at the 2018 Medical Assciatin Annual Meeting and Business Sessin t be held at the Renaissance Htel in Mntgmery, Alabama. Fellws, Residents and Students are invited t attend the cnference, visit with Alabama physician recruiters and residency prgrams, and attend a cmplimentary scial hur n Friday, April 13th. Any research cnducted ver the past fur years will be cnsidered fr this sympsium. The cnference is FREE! Wh can submit and abstract? All medical students (includes medical students enrlled in jint degree prgrams, e.g., MD/PhD, MD/MPH, DO etc.) wh are students at ne f the fur Alabama medical schls Fellws and Residents wh are practicing in the State f Alabama Members f the Medical Assciatin (membership is free fr residents and students) General Requirements Yu must be present t discuss yur research during the scheduled judging perid the days f the event. Anther individual may nt present in yur place. Only ne persn can present and is eligible t win. By submitting an abstract and/r pster, yu certify that: The research, abstract, and pster are yur riginal wrk r riginal wrk cnducted by yu and ther authrs All c-authrs are apprpriately credited fr their cntributins and have been infrmed f the submissin. Vilatin f these requirements will result in disqualificatin frm the sympsium. Abstract Deadline Abstracts fr the 2018 Medical Assciatin Research Sympsium will be accepted beginning Nvember 6, 2017 and are due n March 15, All deadlines are 11:59 p.m. central time. General Abstract Criteria Each eligible member may submit nly ne abstract. Multiple abstracts received frm the same submitter will be rejected. Once an abstract is submitted, it cannt be mdified (i.e., an updated versin will nt be accepted later, even if it is befre the submissin deadline). Please thrughly prfread yur abstract befre submitting it. Only the first authr will be able t present if accepted; c-presentatins will nt be allwed.

2 Submitted abstracts must cnfrm t the frmatting guidelines listed belw (als see abstract frmat example). Abstract Frmat - Research Categry Abstracts submitted under the research categry will include basic science research, mlecular/bilgical research, cntrlled clinical trials, etc. Abstracts that d nt meet these requirements will be rejected. Only abstracts submitted under this categry will be eligible fr the grand prize trip t the 2018 AMA Interim Meeting in San Dieg. Grand Prize winner must be an AMA member in gd standing t attend. First, secnd and third place winners will win a cash prize and will be recgnized n Saturday, April 14th during the Huse f Delegates Business Sessin. Fnt and spacing: The entire abstract must be cmpsed in 12-pint, Times New Rman fnt, and must be duble spaced with 1 margins. Title: Center and bld the abstract title. Authr infrmatin: List authrs and their affiliatins under the title. The member presenting the abstract must be listed as the first authr; the principal investigatr must be listed as the last authr. Include yur phne number, mst frequently checked address, and year in schl (e.g., M3) r prgram year immediately belw the authr infrmatin. Abstracts fr reprts f riginal data: Reprts f riginal data shuld include an abstract f n mre than 350 wrds using the headings listed belw. Fr brevity, parts f the abstract may be written as phrases rather than cmplete sentences. Each sectin shuld include the cntent listed belw. If there are sectins that are nt applicable, please mark as N/A. Imprtance/Backgrund: The abstract shuld begin with a sentence r tw explaining the clinical (r ther) imprtance f the study questin. Objective: State the precise bjective r study questin addressed in the reprt (e.g., T determine whether ). If mre than ne bjective is addressed, the main bjective shuld be indicated and nly key secndary bjectives stated. If a prir hypthesis was tested, it shuld be stated. Design/Methd: Describe the basic design/methdlgy f the study. State the years f the study and the duratin f fllw-up. If applicable, include the name f the study (e.g., the Framingham Heart Study). As relevant, indicate whether bservers were blinded t patient grupings, particularly fr subjective measurements. Setting: Describe the study setting t assist readers t determine the applicability f the reprt t ther circumstances, fr example, general cmmunity, a primary care r referral center, private r institutinal practice, r ambulatry r hspitalized care. Participants: State the clinical disrders, imprtant eligibility criteria, and key scidemgraphic features f patients. The numbers f participants and hw they were selected shuld be prvided (see belw), including the number f therwise eligible individuals wh were apprached but refused. If matching is used fr cmparisn grups, characteristics that are matched shuld be specified. In fllw-up studies, the prprtin f participants wh cmpleted the study must be indicated. In interventin

3 studies, the number f patients withdrawn because f adverse effects shuld be given. Fr selectin prcedures, these terms shuld be used, if apprpriate: randm sample (where randm refers t a frmal, randmized selectin in which all eligible individuals have a fixed and usually equal chance f selectin); ppulatin-based sample; referred sample; cnsecutive sample; vlunteer sample; and cnvenience sample. Interventin(s) fr clinical trials r expsure(s) fr bservatinal studies: The essential features f any interventins r expsures shuld be described, including their methd and duratin. The interventin r expsure shuld be named by its mst cmmn clinical name, and nnprprietary drug names shuld be used. Main utcme(s) and measure(s): Indicate the primary study utcme measurement(s) as planned befre data cllectin began. If the manuscript des nt reprt the main planned utcmes f a study, this fact shuld be stated and the reasn indicated. State clearly if the hypthesis being tested was frmulated during r after data cllectin. Explain utcmes r measurements unfamiliar t a general medical readership. Results: The main utcmes f the study shuld be reprted and quantified, including baseline characteristics and final included/analyzed sample. Include abslute numbers and measures f abslute risks (such as increase/decrease r abslute differences between grups), alng with cnfidence intervals (fr example, 95 percent) r P values. Appraches such as number needed t treat t achieve a unit f benefit may be included when apprpriate. Measures f relative risk als may be reprted (e.g., relative risk, hazard ratis) and shuld include cnfidence intervals. Studies f screening and diagnstic tests shuld reprt sensitivity, specificity and likelihd rati. If predictive value r accuracy is reprted, prevalence r pretest likelihd shuld be given as well. All randmized cntrlled trials shuld include the results f intentin-t-treat analysis, and all surveys shuld include respnse rates. Cnclusins and relevance/discussin and Cnclusin: Prvide nly cnclusins f the study that are directly supprted by the results. Give equal emphasis t psitive and negative findings f equal scientific merit. Als, prvide a statement f relevance indicating implicatins fr clinical practice r health plicy, aviding speculatin and vergeneralizatin. The relevance statement may als indicate whether additinal study is required befre the infrmatin shuld be used in clinical settings. Trial registratin: Fr clinical trials, please include the name f the trial registry, registratin number and URL f the registry, if available. Abstract Frmat - Case Study Categry Abstracts submitted under the Case Study categry will shw ne f the fllwing: Unreprted r unusual side effects r adverse interactins invlving medicatins Unexpected r unusual presentatins f a disease New assciatins r variatins in disease prcesses Presentatins, diagnses and/r management f new and emerging diseases An unexpected assciatin between diseases r symptms An unexpected event in the curse f bserving r treating a patient

4 Findings that shed new light n the pssible pathgenesis f a disease r an adverse effect Abstracts that d nt meet these requirements will be rejected. Abstracts submitted under the Case Study Categry WILL NOT be eligible fr the grand prize trip t the 2018 AMA interim cnference in San Dieg. First, secnd and third place winners will win a cash prize and be recgnized n Saturday, April 14th during the Huse f Delegates Business Sessin. Fnt and spacing: The entire abstract must be cmpsed in 12-pint, Times New Rman fnt, and must be duble spaced with 1 margins. Title: Center and bld the abstract title. Authr infrmatin: List authrs and their affiliatins under the title. The member presenting the abstract must be listed as the first authr; the principal investigatr must be listed as the last authr. Include yur phne number, mst frequently checked address, and year in schl (e.g., M3) r prgram year immediately belw the authr infrmatin. Abstracts fr reprts f riginal case study: Reprts f riginal case study shuld include an abstract f n mre than 350 wrds using the headings listed belw. Fr brevity, parts f the abstract may be written as phrases rather than cmplete sentences. Each sectin shuld include the cntent listed belw. If there are sectins that are nt applicable, please mark as N/A. Intrductin/Backgrund: Abstract shuld begin with a sentence that describes the cntext f the case and its relevance and imprtance/nvelty. Case descriptin: Include infrmatin abut the case in the fllwing sequence: Histry: A brief descriptin f patient s clinical and demgraphic details alng with diagnsis. Physical examinatin: including symptms and signs f disease prcess and/r any diagnstic evaluatins dne. Investigative studies: Including brief details abut treatment r interventins ffered t patient. Infrmatin abut patient s prgress, utcme, r plans fr fllw-up. Include any ther significant details f case. Discussin/Cnclusin: A brief summary (nly a sentence r tw) detailing the atypical presentatin f disease prcess, the deviatin frm standard f care, the rarity r lack f existing literature fr the case, any unique results gathered frm case, r any implicatins that the case may have n the future f medicine. Abstract submissin Yu can submit yur abstract by at medicalstudents@masalink.rg. Abstract authrs will be ntified f their status by as well. Please prvide a gd address s that yur eligibility t participate is cmmunicated t yu quickly and efficiently. Mre infrmatin will be added as necessary t Criteria and Judging During the scheduled pster viewing sessins, judges will visit and examine each research pster. Authrs must be available fr questins during this time and must prepare a 2 4 minute verview f

5 their psters fr the judges. Presenters shuld als be prepared t answers questins abut their research. Evaluatin f abstracts and psters will be based n the fllwing criteria: Clarity f hypthesis. Clear rganizatin f the prject. Effective use f the scientific methd is evident. All significant variables have been identified. Effrts t eliminate bias between cntrl and experimental grups are clear. Results include a discussin f relevant data. The cnclusin is cnsistent with the data and/r bservatins. Ptential pitfalls f the methdlgy r interpretatin have been addressed. The ptential significance f the experiments is placed in the prper perspective. The prject demnstrates a nvel apprach and/r idea. Abstract is in required frm and rganized, including meeting wrd cunt limit. Abstract is well written, cncise and readable. NOTE: Students may nt submit clinical vignettes/case studies/etc.; all student abstracts must be research based. Event schedule Event schedule will be psted nline clser t the event. Pster Presentatin Preparatin Abstracts chsen fr pster presentatin at the sympsium must be prepared in advance n a pster bard, 36" wide x 24" tall r less. Psters may be in a single sheet r in multiple panels, as lng as they adhere t the space requirement. All csts assciated with creatin f the pster will be the respnsibility f entrants. Easels will be prvided by the Medical Assciatin. Presenters must set up their psters at the scheduled time prir t the pster sessin. Display Pster presentatin participants must be present t discuss their research during the scheduled pster judging and viewing. Review the event schedule nline fr the full schedule, including set-up times, and awards presentatin. Remval All psters must be remved immediately after the pster event. The Medical Assciatin will nt be respnsible fr psters left behind Other cnsideratins Presenters may want t have cpies f their presentatins available n standard printing paper. Sme students like t have cpies available in case thse attending the sympsium wuld like a cpy. This is nt a requirement.